The Maillard reaction, first described during the early 20th century, originally referred to the browning reaction that occurs between amino acids and sugars during the cooking and processing of foods. This reaction contributes to the color, taste, aroma, and texture of foods, and also affects their nutritional and toxicological properties. The Maillard reaction, which has been at the crossroads of food and biomedical sciences, is now also known to contribute to the natural and normal aging of tissue proteins and other biomolecules. It is also implicated in the pathologic processes of a range of age-related chronic diseases, including arthritis, atherosclerosis, diabetes, and neurodegenerative diseases. The role of the Maillard reaction in diabetes and its complications has become a major focus of research, leading to a better understanding of the importance of oxidative stress, lipid peroxidation, and hyperlipidemia in diabetic complications.
This volume addresses all of these issues - from food to biomedical sciences - and highlights current research trends, including the identification of new biomarkers, nutrition, and toxicology, and the role of oxidative stress, advanced glycoxidation and lipoxidation end products (AGE/ALEs) in aging and chronic disease. The last section of the book, devoted to recent research on AGE/ALE inhibitors in animal models and clinical trials, assesses the current status of pharmaceutical interventions for retarding the Maillard reaction and the pathophysiology associated with aging and age-related disease.
- ISBN10 157331532X
- ISBN13 9781573315326
- Publish Date 1 August 2005 (first published 1 January 2005)
- Publish Status Out of Stock
- Out of Print 19 April 2010
- Publish Country US
- Imprint New York Academy of Sciences
- Format Paperback
- Pages 956
- Language English